KRAS突变亚型及其与瘤性途径中其他驱动突变的关联
Koushik Mondal1,2, Mahesh Kumar Posa3, Revathi P Shenoy4
1Division of Basic & Translational Research, Saroj Gupta Cancer Centre & Research Institute, MG Road, Kolkata 700063, West Bengal, India.
KRAS突变是癌症的关键驱动因素. 这项研究揭示了常见的KRAS变异与TP53,PIK3CA和APC等其他突变同时发生,影响癌症的进展和治疗.
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
- 生物信息学是一种生物信息学.
背景情况:
- 克拉斯突变是关键的致癌驱动因素.
- 了解与其他驱动器突变的同时发生是有限的.
- 克拉斯相互作用影响癌症的特征.
研究的目的:
- 为了研究KRAS共同突变模式.
- 探索KRAS和其他驱动器突变之间的相关性.
- 评估预后和预测影响.
主要方法:
- 使用了cBioPortal,TCGA,UALCAN和UniProt的数据库.
- 分析了KRAS变异与其他突变的同时发生情况.
- 检查了转录级别的相关性.
主要成果:
- 在PAAD和CRAD中,G12D和G12VKRAS变异与TP53同时发生.
- G12C和G12V KRAS变异与LUAD同时发生.
- 在CRAD中,KRAS显示了与PIK3CA和APC的正转录水平相关性.
结论:
- 与TP53,PIK3CA和APC共同发生的KRAS突变在特定癌症中很普遍.
- 这些共同突变可能会影响癌症信号通路.
- 识别共同突变模式具有重要的治疗影响.
更多相关视频
10:13A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells
Published on: July 3, 2013
07:49Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
相关概念视频
The Ras Gene
Ras is a...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancers Originate from Somatic Mutations in a Single Cell
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
